markets

Windward Bio Debuts on Nasdaq, Shares Surge 68% on IPO Day

Summarized from All Financial Services & Investing

Clinical-stage biotech Windward Bio priced its IPO at $17 per share and closed its first trading day at $28.50 on Nasdaq.

Windward Bio Debuts on Nasdaq, Shares Surge 68% on IPO Day

Windward Bio, a clinical-stage biotechnology company backed by Qiming Venture Partners, made its Nasdaq debut on November 13, 2026, under the ticker symbol WWB, marking a significant milestone for the Shanghai-rooted immunology firm.

The company priced its initial public offering at $17.00 per share, but investor demand pushed the stock sharply higher on its first day of trading. Shares closed at $28.50, representing a gain of roughly 68 percent from the IPO price — a strong opening performance by any measure in the current biotech capital markets environment.

Read more Leverage Shares Launches 2x Long Anthropic ETF as ANT Debuts on Nasdaq →

Windward Bio operates in the immunology space, a field that has drawn sustained institutional interest given the broad therapeutic applications ranging from autoimmune disorders to oncology. As a portfolio company of Qiming Venture Partners, one of Asia's prominent venture capital firms, Windward Bio carries backing with an established track record in life sciences investment.

The listing adds to a growing cohort of Asia-linked biotechs seeking access to U.S. public markets via Nasdaq, a preferred venue for clinical-stage companies that may not yet carry commercial revenue. A strong first-day close can ease subsequent capital raises, though biotech valuations remain sensitive to clinical trial readouts and broader risk appetite.

Continue reading at All Financial Services & Investing.

Frequently Asked Questions

Q.What was Windward Bio's IPO price and first-day closing price?

Windward Bio priced its IPO at $17.00 per share and closed its first day of trading on Nasdaq at $28.50, a gain of approximately 68 percent.

Q.Who is the main investor behind Windward Bio?

Windward Bio is a portfolio company of Qiming Venture Partners, a prominent venture capital firm.

Q.What stock exchange and ticker symbol does Windward Bio trade under?

Windward Bio trades on the Nasdaq stock exchange under the ticker symbol WWB.

More in markets →